Alexis Andrew F
Skin of Color Center at St Luke's-Roosevelt Hospital and Columbia University College of Physicians and Surgeons, New York, NY 10025, USA.
J Dermatolog Treat. 2008;19(4):199-209. doi: 10.1080/09546630802132635.
Acne is a disease that affects millions of people worldwide and requires prompt and effective management of both the physical and psychological sequelae that an individual may experience. The ultimate goal of treatment is to address as many of the pathogenic factors of acne as possible while minimizing side effects. Numerous therapeutic options are available; however, most current treatment options address only one or two of these factors. For this reason, combining single therapies has been the practice since the mid-1970s, beginning with the concomitant use of treatments such as topical vitamin A with systemic tetracyclines or topical benzoyl peroxide. As additional therapeutic options have emerged, dermatologists have also begun to utilize these treatments concomitantly based on their synergistic and multifactorial effects on the different pathogenic factors of acne. This review provides an update of recent advances and data regarding the concomitant use of various anti-acne agents.
痤疮是一种影响全球数百万人的疾病,需要对个体可能经历的身体和心理后遗症进行及时有效的管理。治疗的最终目标是尽可能多地解决痤疮的致病因素,同时将副作用降至最低。有许多治疗选择;然而,目前大多数治疗选择只针对其中一两个因素。因此,自20世纪70年代中期以来,联合单一疗法一直是常见做法,最初是同时使用局部维生素A与全身性四环素或局部过氧化苯甲酰等治疗方法。随着更多治疗选择的出现,皮肤科医生也开始基于这些疗法对痤疮不同致病因素的协同和多因素作用而同时使用它们。本综述提供了关于各种抗痤疮药物联合使用的最新进展和数据。